-+ 0.00%
-+ 0.00%
-+ 0.00%

NURIX THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE 1B/2 COMBINATION STUDY OF BEXOBRUTIDEG IN CHRONIC LYMPHOCYTIC LEUKEMIA

Reuters·10/07/2026 05:02:09